Nearly one million people have taken an experimental coronavirus vaccine developed by China National Pharmaceutical Group (Sinopharm) through the country’s ...
Pfizer Inc and BioNTech could secure emergency U.S. and European authorization for their COVID-19 vaccine next month after final trial results showed ...
A recent analysis by Duke University found that countries have already confirmed purchases for 3.8 billion doses and a further ...
Pfizer Inc said on Monday it was starting a pilot program for COVID-19 immunization in four U.S. states to help ...
The head of the World Health Organization said Monday that a vaccine would not by itself stop the coronavirus pandemic. ...
Moderna Inc’s experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company ...
Johnson & Johnson launched a new large-scale late-stage trial on Monday to test a two-dose regimen of its experimental COVID-19 ...
After Pfizer's claim that the COVID-19 vaccine is more than 90% effective based on initial trial results, a few volunteers ...
With tropical heat, remote island communities and a dearth of ultra-cold freezers, many Asian countries aren’t betting on Pfizer’s experimental ...
November 9 (CNBC) - U.S. pharmaceutical giant Pfizer and German biotech firm BioNTech announced Monday their coronavirus vaccine was more than 90% effective ...
